Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Parasites & Vectors

Fig. 2

From: Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns

Fig. 2

Suitable mass drug administration (MDA) and “Test & Treat” based schemes tailored to the type and level of co-endemicity of three major filarial infections in sub-Saharan Africa. The chart graph shows the overall population that may potentially benefit from different MDA schemes. Abbreviations: ALB, albendazole; DEC, diethylcarbamazine; E, enhanced post-treatment monitoring for rapid determination of potential loiasis-related SAEs; IVM, ivermectin; ITN, insecticide-treated nets; MDA, mass drug administration; MM, medical monitoring at the community during 3–4 days after MDA; R, regular monitoring of drug effects on treated communities; SAE, severe adverse event

Back to article page